CD8A and prostate cancer: In order to mimic metastatic prostate cancer conditions in vivo, the authors isolated ILC2s from tumors of donor mice and cultured them with the LMD cell lines, CD8+ dendritic cells (DCs), ovalbumin (OVA) peptide as well as CD8+ OT-1 T cells.